Porzio Life Sciences InfoCenter Update: Revised AdvaMed Code on HCP Interactions Effective 6/1/22

March 29, 2022

Porzio Life Sciences Enforcement Action Update: New FDA Guidance Examines Patient-Focused Drug Development

March 16, 2022

Porzio Life Sciences Enforcement Action Update: DOJ Will Focus On Clinical Trial Fraud With New Enforcement Policies

February 15, 2022

Porzio, Bromberg & Newman Named a "Legal Technology Trailblazer" by The National Law Journal

February 02, 2022

Porzio Life Sciences EA Update: OPDP Issues Enforcement Letter to Eli Lilly for Misleading Social Media Post

February 01, 2022

Porzio Life Sciences InfoCenter Update: New Facebook Policy Bans Patient Targeted Ads

January 12, 2022

Top Five Trends in Life Sciences Compliance for 2022

January 10, 2022

'Forget Avocado Toast.' How Porzio Bromberg Offers Young Lawyers A Unique Career Path

November 30, 2021

PorzioLS EA Update: Kaléo Pays $12.7 Million to Settle False Claims Act Violations

November 19, 2021

PorzioLS EA Update: Former Aegerion Sales Rep Sentenced to 4 ½ Year Prison Term for Drug Fraud Scheme

November 08, 2021

Porzio Life Sciences x Transparency & Aggregate Spend Hybrid Event 2021

October 27, 2021

Porzio Life Sciences x The Pharmaceutical and Medical Device Ethics and Compliance Congress 2021 (Virtual)

October 27, 2021

PorzioLS EA Update: Accreditation Council for Continuing Medical Education Guidelines Go Into Effect January 2022

October 11, 2021

PorzioLS EA Update: OPDP Analyzes HCP and Consumer Perception of Prescription Drug Promotion

September 07, 2021

PLS Webinar: State Drug Price Transparency Laws: Anticipating Reporting Responsibilities and Making Sure Your Company is Prepared

August 30, 2021

PorzioLS EA Update: OPDP to Focus on Promotion of Prescription Drugs at Medical Conferences in New Research Study

August 23, 2021

Porzio Life Sciences Personnel Announcements

August 17, 2021

PorzioLS EA Update: PhRMA Updates Code on Interactions With Health Care Professionals

August 11, 2021

PorzioLS EA Update: Final Rule on Intended Uses Issued by FDA

August 05, 2021

PorzioLS EA Update: Pharma Co. Settles False Claims Act Allegations, Pays $12.6 Million

June 15, 2021

PLS Webinar: Enforcement Action Trends: Compliance Takeaways from the Incyte Complaint

June 15, 2021

PLS Webinar: Monitoring and Auditing In The Digital Age – An Insiders Perspective

June 15, 2021

PorzioLS InfoCenter Update: OIG Issues Advisory Opinion Regarding Provision of Free Drug

April 13, 2021

NJ Biz: Porzio Life Sciences launches transparency reporting platform

April 05, 2021

Porzio Life Sciences Launches Porzio GST, U.S. and Global Transparency Solution for the Life Sciences Industry

April 05, 2021

2021 Life Sciences Compliance Outlook

March 16, 2021

Texas Introduces Legislation To Amend Current Drug Cost Transparency Law

March 11, 2021

OPDP Issues Untitled Letter For Kardashian DTC Video

March 11, 2021

Rhode Island Has Introduced Drug Price Transparency Legislation

March 04, 2021

The Department of Justice is Watching: Building a Data-Driven Compliance Program (Part 4)

February 02, 2021

The Department of Justice is Watching: Building a Data-Driven Compliance Program (Part 3)

January 26, 2021

The Department of Justice is Watching: Building a Data-Driven Compliance Program (Part 2)

January 19, 2021

The Department of Justice is Watching: Building a Data-Driven Compliance Program (Part 1)

January 12, 2021

Should Compliance have an "on-line" or "off-line" role?

December 16, 2020

Pharmaceutical Executive The Department of Justice is Watching: Building a Data-Driven Compliance Program

November 20, 2020

HHS-OIG Focuses on Speaker Programs with Special Fraud Alert

November 19, 2020

Device Company Settles Open Payment Program Reporting Violation, Agrees to Pay Over $9.2 Million

November 03, 2020

FDA Clarifies Types of Evidence Relevant to Determining the "Intended Use" of a Product

November 02, 2020

Massachusetts Department of Public Health Extends Pharmaceutical and Medical Device Manufacturer Registration Renewal Deadline in Response to COVID-19 Pandemic

July 09, 2020

U.S. Court of Appeals, D.C. Circuit Upholds Decision Against Drug Pricing Rule

June 19, 2020

John Patrick Oroho Interview with Global Business Reports US Biopharmaceuticals 2020

May 29, 2020

Utah Insurance Department Issues Bulletin Regarding Prescription Drug Price Transparency Act; Contact Information Due June 1, 2020

May 11, 2020

Communication During a Pandemic

April 27, 2020

Nevada Department of Health and Human Services Extends Deadline For Essential Drug Report to April 16, 2020

April 09, 2020

Utah Has Introduced Legislation Requiring Manufacturers to Provide a List of Pharmaceutical Sales Representatives; Establishes Reporting and Price Disclosure Requirements

March 19, 2020

West Virginia Introduces Legislation to Require $55,000 Opioid License Fee, Additional Product Registration Fee, and Controlled Substance Distribution Reporting

February 24, 2020

Washington Introduces Legislation Establishing an Impact Fee for Opioid Manufacturers

February 12, 2020

Maine Legislation Requiring Opioid Distribution Reporting and Payment of Manufacturer Fees Became Law Without the Governor's Signature

January 22, 2020

Minnesota Opiate Product Registration Qualification Survey Due to Board of Pharmacy by December 18, 2019

December 06, 2019

Porzio's Family of Companies Receive Community Impact Award

November 22, 2019

Porzio Life Sciences Welcomes Sara R. Simon as a Compliance Associate

October 28, 2019

Porzio Expands to Puerto Rico

October 15, 2019

Colorado Legislation Requiring Drug Manufacturers to Provide Wholesale Acquisition Cost When Marketing to Prescribers Becomes Effective August 2, 2019; Board Determines No Rule Making Needed

July 31, 2019

New Feature! 3PL Added to Porzio Compliance Module

May 13, 2019

Porzio, Bromberg & Newman Ranked the Top Medium-Sized Law Firm in New Jersey by NJBIZ's Best Places to Work

May 02, 2019

French Data Protection Authority Levies €50 Million Fine Against Google in First Significant GDPR Enforcement Action

February 07, 2019

Global Transparency: Risks for Relationships with Healthcare Professionals

January 29, 2019

High Oleic Acid Edible Oils May Now Claim Reduction of Coronary Heart Disease Risk

December 03, 2018

PhRMA Revises Guiding Principles; Direct to Consumer Television Advertisements about Prescription Medicines to Include Pricing Information

November 01, 2018

President Trump Signs Legislation That Expands the Sunshine Act's Definition of Covered Recipient

October 29, 2018

CMS Has Proposed a Rule to Require Drug Pricing Transparency in Direct-to-Consumer Television Advertisements

October 17, 2018

FDA New Draft Guidance: CFUs May Be Disclosed on the Supplement Facts Label for Probiotics

September 12, 2018

Porzio Compliance Digest Continues to Grow to Meet the Needs of the Life Sciences Industry!

August 24, 2018

Global Transparency: The More Things Change, The More They Stay The Same

August 15, 2018

The New Jersey Attorney General Has Proposed Revisions to the Rule Limiting Prescriber Acceptance of Compensation from Pharmaceutical Manufacturers

August 08, 2018

Porzio Life Sciences Expands, Adds Michael T. O'Connor as Vice President of Compliance Technology

June 18, 2018

2018 Life Sciences Healthcare Compliance Survey

April 03, 2018

2017 Porzio Life Sciences Year-in-Compliance

April 01, 2018

Frank Fazio Quoted in PM360 Articled titled "The Trouble with Sampling in the State of Ohio"

February 23, 2018

In Memoriam: Kristin Eberhardt

January 03, 2018

Porzio Life Sciences VP Christopher DePhillips Elected to NJ State Assembly

November 09, 2017

Porzio Life Sciences Celebrates National Customer Service Week 2017

October 02, 2017

Like Beauty and Art, Transparency is in the Eye of the Beholder

August 17, 2017

New and Evolving Requirements for Pharmaceutical Representatives: Chicago, Nevada and Others

July 31, 2017

2016 Life Sciences Healthcare Compliance Survey

June 15, 2017

Congratulations to Christopher DePhillips on His Republican Primary Win in Legislative ‎District 40

June 07, 2017

Porzio Life Sciences Profiled by International Federation of Pharmaceutical Wholesalers

May 18, 2017

Porzio to Host RAPS Event on Developing Regulatory Affairs Expertise

April 20, 2017

Porzio Goes Blue for CASA Child Advocacy Day

April 07, 2017

2016 Year-End Report

February 24, 2017

PorzioLS Welcomes Todd Roth as Director of Compliance Services

February 13, 2017

11th Annual Porzio Compliance Forum: "Compliance Monitoring and Risk Mitigation"

February 10, 2017

Legislation Easing The Registration Process For Pharmaceutical Companies Enacted In New Jersey

December 05, 2016

PorzioLS Volunteers for Homeless Solutions

November 03, 2016

PorzioLS Welcomes Christopher P. DePhillips

November 01, 2016

Frank Fazio Testifies Before New Jersey Assembly in Support of State Biotech Companies

October 06, 2016

Porzio Life Sciences Celebrates National Customer Service Week 2016

October 04, 2016

A Milestone Moment (or a Dead Jellyfish) for the Global Transparency Movement

August 15, 2016

NJ Senate Passes Porzio-Supported Bill S2024, Easing the Registration Process for NJ Pharmaceutical Companies

July 22, 2016

Frank Fazio Testified Before the NJ Senate Health Committee in Support of Bill S2024

May 16, 2016

Porzio Compliance Digest Now Includes More Advertising & Promotion Enforcement Letters

May 12, 2016

Chrissy Bradshaw Quoted in the Pharmaceutical Executive Article, "Disclosure D-Day Draws Near In Europe"

April 12, 2016

Aggregate Spend Goes Global: John P. Oroho Interviewed by MedCity News

March 30, 2016

2015 State of Life Sciences Healthcare Compliance Survey

March 24, 2016

HCP Payments Transparency Outside of the US: An Evolving Complex Environment with Implications for Medical Device Companies

March 23, 2016

Transparency Going Global: How Reporting in the US Matches Up to the O-US Reporting Regime

March 03, 2016

The Sun Never Sets on Transparency

March 01, 2016

The Last Two Years: A Summary of 2014 - 2015 Office of Prescription Drug Promotion (OPDP) Enforcement and Relevant FDA Guidance

March 01, 2016

2015 Year-End Report

February 24, 2016

Porzio Named Top "Notable Smaller Firm" in Life Sciences Law Firm Index

January 18, 2016

Porzio Life Sciences Website Receives 2015 W³ Silver Award

December 22, 2015

10th Annual Porzio Compliance Forum: "Compliance 2.0 - The Next Level"

December 03, 2015

PorzioLS Welcomes Marc I. Eida as a Compliance Associate

November 30, 2015

Keren F. Bisnauth Joins PorzioLS as a Compliance Associate

November 09, 2015

Ingrid A. Pelzer to be a Panelist During Careers in Compliance Event on October 8th, 2015

October 08, 2015

Porzio Life Sciences Celebrates National Customer Service Week 2015

October 05, 2015

PorzioLS Welcomes New Compliance Associate Theodore Rosini

September 22, 2015

Ready Or Not, Full Speed Ahead For The Global Transparency Movement

August 17, 2015

PorzioLS Expands NC Life Sciences Presence as a NCBIO Member

August 03, 2015

Porzio Announces Change of New England Address

June 03, 2015

Porzio Life Sciences Offers Global Compliance and Commercialization Services with Launch of Porzio GST and Netherlands Office

April 17, 2015

2014 Year-End Report

February 15, 2015

2014 Highlights for Promotional Review Professionals: FDA Enforcement and Guidance

January 20, 2015

Consent: Find Out What it Means to You

January 01, 2015

Porzio Life Sciences Announces New Appointments to Support Expanding Solutions

November 12, 2014

Transparency Update: Status of Sunshine Act Compliance

November 04, 2014

Porzio Life Sciences Celebrates National Customer Service Week 2014

October 06, 2014

Sunshine Abroad: Do Start Believin' - The Global Transparency Journey for the Life Sciences Industry

October 02, 2014

Shoot First… Michigan Imposes New Requirements On The Pharmaceutical Supply Chain

September 24, 2014

Massachusetts Life Science Companies: Stuck Between A Rock And A Hard Place

September 05, 2014

Do Start Believin': The Life Sciences Industry's Journey to Global Transparency

August 01, 2014

Transparency is Sweeping the Globe

July 01, 2014

Industrial Site Recovery Act: An Environmental Consideration For New Jersey Life Sciences Facilities

April 01, 2014

FDA’s Office of Prescription Drug Promotion (OPDP) Enforcement: A Summary of 2013 Warning and Untitled Letters

February 27, 2014

Porzio Life Sciences Goes Global

January 24, 2014

Getting the Deal Through: Life Sciences 2014 - United States Chapter Life Sciences in 24 Jurisdictions Worldwide

December 23, 2013

Holland. The Original Cool.

October 23, 2013

Global Application of the Sunshine Act's Reporting Requirements

September 24, 2013

Sunshine Abroad: Evaluating Global Regulations & Transparency Trends

August 21, 2013

The Ongoing Global Transformation in Life Sciences Transparency

August 01, 2013

EFPIA Leads the Self-Regulation Charge to Try to Avoid Government-Imposed Transparency

July 14, 2013

Here Comes The Sunshine Act - This Time, In Europe

June 25, 2013

An IMDA Article on Frank Fazio’s "Are you Licensed to Sell?" Presentation

June 10, 2013

Australia Takes Center Stage in the Global Debate Over Life Sciences Transparency: Legislation vs. Self Regulation

March 15, 2013

Chrissy Bradshaw and Sarah Canberg Quoted in Article on the Sunshine Act’s Complexity

February 20, 2013

Transparency Forecast: Sunshine Ahead!

February 14, 2013

The Sunshine Act

February 14, 2013

Michelle Axelrod and Ed Crowe Present at MassDevice Big 100 Roundtable West

December 11, 2012

Pharmaceutical and Medical Device Compliance Manual Contributing Author

October 11, 2012

Frank Fazio Quoted In Article on Medical Device Licensing Required by States

September 28, 2012

Frank Fazio Quoted In Article on Medical Device Licensing Required by States

September 28, 2012

Prescription Drug Sample Transparency Regulations

August 30, 2012

The Trend Towards Global Transparency: A Challenging New World for the Life Sciences Industry

August 14, 2012

Pharmaceutical Sales Representatives Exempt From Overtime

June 22, 2012

Understanding the Sunshine Act: Dispersing the Clouds of Confusion

March 19, 2012

Are Pharma Sales Reps Exempt From Overtime Pay?

February 13, 2012

Getting the Deal Through: Life Sciences 2012 - United States Chapter

February 13, 2012

CMS Publishes Draft Regulations to Implement the Sunshine Act

December 19, 2011

New Technology Streamlines Aggregate Spend Reporting

November 21, 2011

Aggregate Spend Boot Camp Faculty from Porzio

August 23, 2011

Risks and Enforcement Issues of Testimonials is Subject of Presentation

August 23, 2011

Aggregate Spend New Version Release Offers Customers Enhanced Alert Functionality

June 30, 2011

Scalable Aggregate Spend Solutions is Presentation Topic

June 24, 2011

Aggregate Spend and Federal Sunshine Act: Topic at Seton Hall Law Healthcare Compliance Certification Program

June 13, 2011

What’s Your Pharmaspective®? Announcing the Newest Resource for the Life Sciences Industry

January 17, 2011

Porzio Opens a Massachusetts Office to Serve Life Sciences Companies

December 27, 2010

PorzioLS Launches New Government Prosecutions Database

December 10, 2010

PPS Launches New Sample Accountability Service to Establish Company-Specific Significant Loss Thresholds

October 07, 2010

Minimizing Product Liability Risk Topic of DIA Session

June 14, 2010

Taking Stock of the Marketing Restrictions and Prohibitions of Academic Medical Centers

May 01, 2010

Thriving Through Turmoil: Managing Sales and Marketing Regulation of the Medical Device Industry

April 01, 2010

The Perfect Storm: Weathering the Convergence of Federal, State and Industry Regulations Impacting Pharmaceutical Sales and Marketing Representatives

February 01, 2010

PPS Honored By NJBiz As One of NJ's Fastest Growing Companies

November 16, 2009

What's All the Commotion Over Aggregate Spend?

September 01, 2009

Court Prescribes No Overtime for Pharmaceutical Reps

June 01, 2009

Sales Rep Nightmares: Emerging Issues in Marketing Compliance

May 28, 2009

Over-the-Counter and Prescription Drug Manufacturers are Granted a One Year Reprieve from the Burdensome Requirements of the Consumer Product Safety Improvement Act

March 09, 2009

The End or Just the Beginning? Exploring Federal Preemption of State and Distribution Laws

February 01, 2009

DDMAC Reasserts Its Oversight of Promotion Directed Not Only to Physicians, But Also to P&T Committees

September 11, 2007

Newly Enacted Nevada Statute Requires Adoption of a "Marketing Code of Conduct"

June 18, 2007

Online DTC: Marketing Push Meets Consumer Pull

May 30, 2007

Can Prosecutors Use Data from Sample Distribution as Evidence of Off-Label Promotion?

May 21, 2007

Regulatory updates issued each year


Of articles published


Industry Accolades